Department of Preventive Cardiology & Medicine, Eternal Heart Care Centre & Research Institute, Jaipur, India.
Indian Heart J. 2023 Sep-Oct;75(5):327-334. doi: 10.1016/j.ihj.2023.08.003. Epub 2023 Aug 25.
Premature coronary artery disease (CAD) is endemic in India. Global Burden of Diseases study has reported that it led to 286,000 deaths in 2019 in India. Many of these patients have standard risk factors but a third have none. Clinical risk algorithms and imaging provide limited risk information in premature CAD. CAD is multifactorial and studies have now focused on the predictive capability of clusters of genes and single nucleotide polymorphisms (SNPs) using gene risk score (GRS). Older studies combined data from 10 to 12 genes and 100-500 SNPs to calculate GRS, however, following the advent of genome-wide association studies (GWAS), millions of SNPs have been incorporated. Studies have reported that GWAS-based GRS may be more discriminative than conventional tools. Recent studies, especially among South Asians, have reported that GRS improves net reclassification by 15% (12-19%) for younger individuals. Aggressive lifestyle interventions and lipid-lowering therapies can ameliorate risk in high-GRS individuals and potentially prevent premature CAD.
早发性冠心病(CAD)在印度很普遍。全球疾病负担研究报告称,2019 年印度有 28.6 万人因此死亡。这些患者中有许多人有标准的风险因素,但三分之一的人没有。临床风险算法和影像学在早发性 CAD 中提供的风险信息有限。CAD 是多因素的,现在的研究已经集中在使用基因风险评分(GRS)的基因和单核苷酸多态性(SNP)簇的预测能力上。早期的研究将 10 到 12 个基因和 100-500 个 SNP 的数据结合起来计算 GRS,然而,随着全基因组关联研究(GWAS)的出现,已经纳入了数百万个 SNP。研究报告称,基于 GWAS 的 GRS 可能比传统工具更具判别力。最近的研究,特别是在南亚人群中,报告称 GRS 可以提高年轻个体 15%(12-19%)的净重新分类率。积极的生活方式干预和降脂治疗可以改善高 GRS 个体的风险,并有可能预防早发性 CAD。